employed BGI Stereo‐seq to analyse four ER+HER2– breast cancer samples (two endocrine‐sensitive and two endocrine‐resistant) from patients undergoing endocrine therapy post‐surgery and chemotherapy. Here, ERBB2 is linked to breast cancer.